Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
28/05/202407:15Business WireCoya Therapeutics Announces Inclusion in the MSCI USA Micro Cap IndexNASDAQ:COYACoya Therapeutics Inc
28/05/202407:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRGXCARGO Therapeutics Inc
28/05/202407:14Business WireMEDSIR & Debiopharm Initiate Clinical Collaboration to Explore Potential Synergy of Debio 0123 & Sacituzumab Govitecan in Advanced Breast Cancer
28/05/202407:14Business WireMEDSIR ET DEBIOPHARM ENTAMENT UNE COLLABORATION CLINIQUE POUR EXPLORER LA SYNERGIE POTENTIELLE ENTRE DEBIO 0123 ET LE SACITUZUMAB GOVITECAN DANS LE CANCER DU SEIN AVANCÉ
28/05/202407:14PR Newswire (US)InfoBionic.Ai and HBox.ai Ink Partnership to Offer the First AI-Driven "Cardiology Clinic of the Future"
28/05/202407:14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - TF.DB.FTSX:TF.DB.FTimbercreek Financial Corp
28/05/202407:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ENLVEnlivex Therapeutics Ltd
28/05/202407:13GlobeNewswire Inc.Lerøy Seafood Group ASA: Ordinary General Shareholders Meeting heldTG:Z1LLeroy Seafood Group
28/05/202407:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMPXAmprius Technologies Inc
28/05/202407:13PR Newswire (US)Standard Motor Products, Inc. STABIL Facility Earns PACCAR 2023 10 PPM Award
28/05/202407:13PR Newswire (US)UEFA Grants Exclusive Rights to Hisense as Official VAR Screen Provider for UEFA EURO 2024™
28/05/202407:12GlobeNewswire Inc.Enlivex Therapeutics Announces up to $15 Million Registered Direct OfferingNASDAQ:ENLVEnlivex Therapeutics Ltd
28/05/202407:11PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - TF.DB.FTSX:TF.DB.FTimbercreek Financial Corp
28/05/202407:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:VSTOVista Outdoor Inc
28/05/202407:10Business WireEnergy Transfer to Acquire WTG Midstream in a $3.25 Billion TransactionNYSE:ETEnergy Transfer LP
28/05/202407:10PR Newswire (US)RedCloud CEO Justin Floyd Advocates for Open Commerce and AI to Combat Counterfeits
28/05/202407:10PR Newswire (US)Constructor Named a Visionary in the First-Ever Gartner Magic Quadrant for Search and Product Discovery
28/05/202407:09Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CALTCalliditas Therapeutics AB
28/05/202407:09Business WireLe lancement de la production du 400e Cessna Citation Latitude souligne sa position de leader sur le marché des jets d’affaires de taille moyenneNYSE:TXTTextron Inc
28/05/202407:08PR Newswire (US)Upfront, Maverick Systems, The Studio Home, and Billions Join Equity Angels' First Proptech Cohort
28/05/202407:08PR Newswire (US)LONGi announces the "Lighthouse Project" to expand the agile intelligent manufacturing to more of its own production bases across the globe
28/05/202407:07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:VSTOVista Outdoor Inc
28/05/202407:07PR Newswire (US)RADPAIR and Radiopaedia.org Forge Strategic Partnership to Revolutionize Radiology Reporting with PAIR Insights
28/05/202407:07PR Newswire (US)The Op Games Launches MONOPOLY®: Family Guy Edition
28/05/202407:07PR Newswire (US)SHIPLEY DO-NUTS CELEBRATES NATIONAL DONUT DAY WITH A DELICIOUS DEAL
28/05/202407:07PR Newswire (US)SKULLCANDY UNVEILS LIMITED-EDITION TERRAIN XL SPEAKERS IN CELEBRATION OF PRIDE MONTH
28/05/202407:06GlobeNewswire Inc.Bryan Texas Surpasses $2M Milestone in Surplus SalesNASDAQ:LQDTLiquidity Services Inc
28/05/202407:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:OCOwens Corning Inc
28/05/202407:05GlobeNewswire Inc.Form 8.3 - International Distributions Services Plc
28/05/202407:05GlobeNewswire Inc.Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMDNASDAQ:OTLKWOutlook Therapeutics Inc